Good afternoon, everyone, and thank you for joining us today. 2025 was a year of exceptional execution, one that proved the strength of our business as we continue to build a world-leading financial ...

HeartFlow delivered 40% sales growth in 2025, with revenue surpassing $176 million and strong Q4 momentum. Learn more about HTFL stock here.

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) Q3 2026 Earnings Call Transcript March 17, 2026 KESTRA MEDICAL TECHNOLOGIES, LTD. misses on earnings expectations. Reported EPS is $-0.61 EPS, ...

Parade and Steller have unveiled the 40 finalists in the nationwide search for America’s Favorite Small Town, a campaign ...

All animal studies were performed according to protocols approved by the University Committee on Animal Resources at the University of Rochester Medical ...